Benitec Biopharma Inc. Shareholders' Equity
Benitec Biopharma Inc. (BNTC) had Shareholders' Equity of $177.01 million as of 2026-06-30, per its 10-K filed 2026-09-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-09-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $177.01M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $183.33M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $187.36M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $93.60M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $177.01M 10-K · filed 2026-09-14 |
| 2026-03-31 | $183.33M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $187.36M 10-Q · filed 2026-05-14 |
| 2025-09-30 | $93.60M 10-Q · filed 2026-05-14 |
| 2025-06-30 | $97.30M 10-K · filed 2026-09-14 |
| 2025-03-31 | $97.57M 10-Q · filed 2026-05-14 |
| 2024-12-31 | $75.94M 10-Q · filed 2026-05-14 |
| 2024-09-30 | $64.18M 10-Q · filed 2026-05-14 |
| 2024-06-30 | $47.25M 10-K · filed 2026-09-14 |
| 2024-03-31 | $11.50M 10-Q · filed 2025-05-14 |
| 2023-12-31 | $15.47M 10-Q · filed 2025-05-14 |
| 2023-09-30 | $22.31M 10-Q · filed 2025-05-14 |
| 2023-06-30 | $202.00K 10-K/A · filed 2026-03-20 |
| 2023-03-31 | $4.71M 10-Q · filed 2024-05-13 |
| 2022-12-31 | $8.99M 10-Q · filed 2024-05-13 |
| 2022-09-30 | $14.61M 10-Q · filed 2024-05-13 |
| 2022-06-30 | $2.88M 10-K · filed 2024-09-26 |
| 2022-03-31 | $7.52M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $10.84M 10-Q · filed 2023-05-15 |
| 2021-09-30 | $15.47M 10-Q · filed 2023-05-15 |
| 2021-06-30 | $20.01M 10-K · filed 2023-09-21 |
| 2021-03-31 | $10.93M 10-Q · filed 2022-05-16 |
| 2020-12-31 | $14.63M 10-Q · filed 2022-05-16 |
| 2020-09-30 | $7.74M 10-Q · filed 2022-05-16 |
| 2020-06-30 | $10.24M 10-K · filed 2022-09-02 |
| 2020-03-31 | $12.34M 10-Q · filed 2021-05-12 |
| 2019-12-31 | $15.25M 10-Q · filed 2021-05-12 |
| 2019-09-30 | $16.97M 10-Q · filed 2021-05-12 |
| 2019-06-30 | $16.59M 10-K · filed 2021-09-20 |
| 2018-06-30 | $13.84M 10-K · filed 2020-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |